Welcome to our dedicated page for Curtiss Wright SEC filings (Ticker: CW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Curtiss-Wright Corporation filings document financial results, governance matters and capital actions for an operating company serving Aerospace & Defense, commercial nuclear power, process and industrial markets. Recent Form 8-K reports furnish quarterly and annual results releases, webcast presentations and outlook commentary tied to the company’s operating markets.
Proxy materials and annual-meeting reports cover director elections, independent auditor ratification and advisory executive-compensation votes. Other Form 8-K disclosures describe common-stock repurchase authorizations, Rule 10b5-1 trading plans, potential repurchase methods and related risk language under the Exchange Act.
CW reports a proposed sale of common stock via Form 144 by an issuer-affiliated holder. The filing lists 220 common shares tied to a Restricted Stock Vesting event dated 03/16/2026. It also discloses prior sales of 652 common shares on 02/04/2026 by John Watts.
Robert Freda reported a proposed disposition of Common Stock on a Form 144. The notice lists restricted stock vesting dated 03/16/2026 and identifies UBS Financial Services Inc. The filing also records a prior sale of 418 shares on 02/04/2026.
CW filed a notice of proposed sale under Rule 144 for 3,225 shares of Common Stock related to restricted stock vesting, reported with an effective date of 03/16/2026. The filing also records a prior sale of 9,327 shares by Lynn Bamford on 02/04/2026. Shares outstanding are listed as 36,869,530 as of 03/17/2026.
CW reported a Form 144 notice related to the proposed resale of common stock.
The filing lists a Restricted Stock Vesting event dated 03/16/2026 and shows recent dispositions by Gary Ogilby: 435 shares on 02/04/2026 and 625 shares on 02/05/2026. The filing identifies the exchange as NYSE.
CW filed a Form 144 reporting a proposed sale of 918 shares of common stock associated with restricted stock vesting on 03/16/2026. The filing also lists prior sales by K. Christopher Farkas of 2,665 shares on 02/04/2026 and 3,105 shares on 02/18/2026.
Watts John C reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corp reported that EVP & Chief Growth Officer John C. Watts received a grant of 183 time-based restricted stock units under the company’s 2024 Omnibus Incentive Plan. Each RSU represents one share of common stock and will cliff vest three years after the March 9, 2026 grant date. Following this award, his reported RSU total is 1,407 units, including dividend credits earned on prior grants.
Freda Robert F reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corp reported that Senior VP & Treasurer Robert F. Freda received a grant of 82 restricted stock units (RSUs) on March 9, 2026 under the company’s 2024 Omnibus Incentive Plan. Each RSU represents one share of common stock and will cliff vest after a three-year period from the grant date.
The RSUs were granted as an employee benefit with no purchase price. Following this award and related dividend credits on prior grants, Freda now holds a total of 4,565 RSUs directly.
Ogilby Gary A reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corporation reported that Senior VP & Corporate Controller Gary A. Ogilby received a grant of 108 restricted stock units under the company’s 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to one share of common stock, granted as an employee benefit with no cash purchase price.
The RSUs will cliff vest after a three-year vesting period from the March 9, 2026 grant date. Following this award, Ogilby now holds 4,820 RSUs directly, a figure that also reflects dividend credits earned on prior outstanding grants.
Curtiss-Wright executive George P. McDonald reported an equity award and corrected his share count. He received a grant of 304 time-based restricted stock units under the 2024 Omnibus Incentive Plan, each representing one share of common stock, which will cliff vest after a three-year period from the March 9, 2026 grant date.
The filing also corrects his previously reported common stock ownership, noting that 2,064 shares acquired through employee benefit transactions before he became an executive officer were inadvertently omitted from his earlier Form 3. Following these updates, he directly holds 4,011 shares of common stock and 1,462 restricted stock units, including dividend credits on prior grants.
Rayment Kevin reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Executive VP and COO Kevin Rayment received a grant of 652 time-based restricted stock units under the company’s 2024 Omnibus Incentive Plan. Each unit represents a contingent right to one share of common stock and will cliff vest after a three-year period from the March 9, 2026 grant date.
The units were granted as an employee benefit with no purchase price, and Rayment’s total reported restricted stock unit balance after this award is 6,432 units, which includes dividend credits earned on prior grants.